Related references
Note: Only part of the references are listed.Pain management with opioids in adults
Lori S. Montgomery
JOURNAL OF NEUROSCIENCE RESEARCH (2022)
The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic StudyS
Erin C. Berthold et al.
DRUG METABOLISM AND DISPOSITION (2022)
The respiratory depressant effects of mitragynine are limited by its conversion to 7-OH mitragynine
Rob Hill et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal
Lisa L. Wilson et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2021)
Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for μ-Opioid Receptor and Opioid-Like Behavioral Effects in Ratss
Samuel Obeng et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2021)
Oxidative Metabolism as a Modulator of Kratom's Biological Actions
Soumen Chakraborty et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths - United States, 2013-2019
Christine L. Mattson et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Race, pain, and opioids among patients with chronic pain in a safety-net health system
Nimah Haq et al.
DRUG AND ALCOHOL DEPENDENCE (2021)
Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery
Samuel Obeng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2021)
Investigation of the Adrenergic and Opioid Binding Affinities, Metabolic Stability, Plasma Protein Binding Properties, and Functional Effects of Selected lndole-Based Kratom Alkaloids
Samuel Obeng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Evaluating kratom alkaloids using PHASE
Christopher R. Ellis et al.
PLOS ONE (2020)
Mitragynine, bioactive alkaloid of kratom, reduces chemotherapy-induced neuropathic pain in rats through α-adrenoceptor mechanism
Jeffery D. Foss et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
CYP450-Mediated Metabolism of Mitragynine and Investigation of Metabolites in Human Urine
Stephanie Basiliere et al.
JOURNAL OF ANALYTICAL TOXICOLOGY (2020)
Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy
Shyam H. Kamble et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
Lyophilized Kratom Tea as a Therapeutic Option for Opioid Dependence
Lisa L. Wilson et al.
DRUG AND ALCOHOL DEPENDENCE (2020)
Simultaneous quantification of ten key Kratom alkaloids in Mitragyna speciosa leaf extracts and commercial products by ultra-performance liquid chromatography-tandem mass spectrometry
Abhisheak Sharma et al.
DRUG TESTING AND ANALYSIS (2019)
The effects of mitragynine and morphine on schedule-controlled responding and antinociception in rats
Takato Hiranita et al.
PSYCHOPHARMACOLOGY (2019)
7-Hydroxymitragynine Is an Active Metabolite of Mitragynine and a Key Mediator of Its Analgesic Effects
Andrew C. Kruegel et al.
ACS CENTRAL SCIENCE (2019)
The Effects of Morphine, Baclofen, and Buspirone Alone and in Combination on Schedule-Controlled Responding and Hot Plate Antinociception in Rats
Jenny L. Wilkerson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
Alternatives to Opioid Analgesia in Small Animal Anesthesia: Alpha-2 Agonists
Alexander Valverde et al.
VETERINARY CLINICS OF NORTH AMERICA-SMALL ANIMAL PRACTICE (2019)
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice
Jenny L. Wilkerson et al.
NEUROPHARMACOLOGY (2017)
Additives used to reduce perioperative opioid consumption 1: Alpha2-agonists
Peter H. Tonner
BEST PRACTICE & RESEARCH-CLINICAL ANAESTHESIOLOGY (2017)
Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism, Which Do Not Recruit β-Arrestin-2
Andras Varadi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
The Selective Monoacylglycerol Lipase Inhibitor MJN110 Produces Opioid-Sparing Effects in a Mouse Neuropathic Pain Model
Jenny L. Wilkerson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine
Alicia G. Lydecker et al.
JOURNAL OF MEDICAL TOXICOLOGY (2016)
Discriminative stimulus properties of mitragynine (kratom) in rats
Norsyifa Harun et al.
PSYCHOPHARMACOLOGY (2015)
Kratom (Mitragyna speciosa) dependence, withdrawal symptoms and craving in regular users
Darshan Singh et al.
DRUG AND ALCOHOL DEPENDENCE (2014)
Morphine and Clonidine Combination Therapy Improves Therapeutic Window in Mice: Synergy in Antinociceptive but Not in Sedative or Cardiovascular Effects
Laura S. Stone et al.
PLOS ONE (2014)
The Potential for Misuse and Abuse of Medications in ADHD: A Review
David B. Clemow et al.
POSTGRADUATE MEDICINE (2014)
Antinociceptive Action of Isolated Mitragynine from Mitragyna Speciosa through Activation of Opioid Receptor System
Abdul Rahman Shamima et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2012)
Involvement of imidazoline and opioid receptors in the enhancement of clonidine-induced analgesia by sulfisoxazole
Mustufa Boxwalla et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2010)
alpha(2)-Agonists as Analgesic Agents
Maria Paola Giovannoni et al.
MEDICINAL RESEARCH REVIEWS (2009)
Interest of alpha(2)-adrenergic agonists and antagonists in clinical practice: Background, facts and perspectives
Pierre-Antoine Crassous et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2007)
An overview of drug combination analysis with isobolograms
Ronald J. Tallarida
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Neurobiology of executive functions: Catecholamine influences on prefrontal cortical functions
AFT Arnsten et al.
BIOLOGICAL PSYCHIATRY (2005)
α2-adrenergic receptor subtypes -: Novel functions uncovered in gene-targeted mouse models
M Brede et al.
BIOLOGY OF THE CELL (2004)